Statement of Chair Lina M. Khan In the Matter of Caremark/ESI/Optum
Date
By
Lina M. Khan, Former Chair and Commissioner
Matter Number
241 0005
File
Displaying 1 - 20 of 50
Concurring Statement of Commissioner Andrew N. Ferguson Joined by Commissioner Melissa Holyoak Regarding the Second Pharmacy Benefit Managers Interim Staff Report
Date
By
Andrew N. Ferguson, Chairman;
Melissa Holyoak, Commissioner
Matter Number
P221200
FTC Releases Second Interim Staff Report on Prescription Drug Middlemen
Date
The Federal Trade Commission today published a second interim staff report on the prescription drug middleman industry, which focuses on pharmacy benefit managers’ (PBMs) influence over specialty...
FTC Announces Tentative Agenda for January 14 Open Commission Meeting
Date
Today, Federal Trade Commission Chair Lina M. Khan announced that an open meeting of the Commission will be held virtually on Tuesday, January 14, 2025. The open meeting will commence at 11 a.m. ET...
Statement of Chair Lina M. Khan In the Matter of Cooperativa de Farmacias Puertoriqueñas
Date
By
Lina M. Khan, Former Chair and Commissioner
FTC Approves Modification of Cooperativa De Farmacias Puertorriqueñas Final Commission Order
Date
Following a public comment period, the Federal Trade Commission has approved a petition by Cooperativa De Farmacias Puertorriqueñas, a Puerto Rican cooperative of independent pharmacy owners, to...
Statement of Commissioner Melissa Holyoak In the Matter of Cooperativa De Farmacias Puertorriqueña
Date
By
Melissa Holyoak, Commissioner
Matter Number
C4374
FTC Seeks Public Comments on Cooperativa De Farmacias Puertorriqueñas Request to Modify Final Commission Order
Date
The Federal Trade Commission is seeking public comment on a petition by a Puerto Rican cooperative of independent pharmacy owners, Cooperativa De Farmacias Puertorriqueñas, also known as Coopharma...
FTC Reaches Proposed Settlement with Surescripts in Illegal Monopolization Case
Date
The Federal Trade Commission filed a proposed order that would prohibit health information technology company Surescripts from engaging in exclusionary conduct and executing or enforcing non-compete...
FTC Announces Tentative Agenda for July 20 Open Commission Meeting
Date
Today, Federal Trade Commission Chair Lina M. Khan announced that an open meeting of the Commission will be held virtually on Thursday, July 20, 2023. The open meeting will commence at 11am ET and...
FTC Further Expands Inquiry Into Prescription Drug Middlemen Industry Practices
Date
As part of its ongoing study on pharmacy benefit managers (PBMs) and their impact on the accessibility and affordability of prescription drugs, the Federal Trade Commission has issued a compulsory...
FTC, DOJ Issue Summary on Joint Pharmaceutical Merger Analysis Workshop
Date
The Federal Trade Commission and the U.S. Department of Justice, Antitrust Division released a summary of a two-day workshop that explored new approaches to enforcement of the antitrust laws in the...
FTC Deepens Inquiry into Prescription Drug Middlemen
Date
As part of its ongoing inquiry into pharmacy benefit managers (PBMs) and their impact on the accessibility and affordability of prescription drugs, the Federal Trade Commission has issued compulsory...
FTC to Ramp Up Enforcement Against Any Illegal Rebate Schemes, Bribes to Prescription Drug Middleman That Block Cheaper Drugs
Date
The Federal Trade Commission announced that it will ramp up enforcement against any illegal bribes and rebate schemes that block patients’ access to competing lower-cost drugs. The enforcement policy...
Public Statement
Oral Remarks of Christine S. Wilson at Open Commission Meeting on June 16, 2022
Date
Statement of Chair Lina M. Khan Regarding 6(b) Study of Pharmacy Benefit Managers
Date
By
Lina M. Khan, Former Chair and Commissioner
Displaying 1 - 20 of 50